I am the CEO of Concarlo, a pre-clinical oncology company developing therapeutics targeting drug-resistant cancers. Our unique technology and target will be ready for clinical trial in 2 years. We plan to first enter the billion dollar drug resistant breast cancer market. I would be happy to connect on SmartMoneyMatch and start the dialogue to see how we can cooperate.